Melvyn Kahan

Targeting C-reactive protein for the treatment of cardiovascular disease

Mark B. Pepys, Gideon M. Hirschfield, Glenys A. Tennent et al. · Nature · 2006 · 669 citations

Inflammation, Cardiovascular Disease, Medicine +5

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

Karl Bodin, Stéphan Ellmerich, Melvyn Kahan et al. · Nature · 2010 · 329 citations · Full text

Alzheimer's Disease, Immunology, Pathology +3

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice

Gideon M. Hirschfield, J. Ruth Gallimore, Melvyn Kahan et al. · Proceedings of the National Academy of Sciences · 2005 · 192 citations · Full text

Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

Mark B. Pepys, Philip N. Hawkins, Melvyn Kahan et al. · Circulation Research · 2005 · 136 citations · Full text

Bacterial Products, Immunology, C-reactive Protein Itself +19

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice

Glenys A. Tennent, Winston L. Hutchinson, Melvyn Kahan et al. · Atherosclerosis · 2007 · 97 citations

Inflammation, Inflammatory Disease, Autoimmune Disease +8